Legal & General Group Plc Sells 61,956 Shares of Envista Holdings Corporation $NVST

Legal & General Group Plc lessened its position in Envista Holdings Corporation (NYSE:NVST) by 19.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 250,956 shares of the company’s stock after selling 61,956 shares during the quarter. Legal & General Group Plc owned 0.15% of Envista worth $5,448,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in NVST. Royal Bank of Canada increased its stake in Envista by 26.6% in the first quarter. Royal Bank of Canada now owns 23,240 shares of the company’s stock valued at $401,000 after acquiring an additional 4,885 shares during the last quarter. Millennium Management LLC grew its stake in shares of Envista by 218.6% during the first quarter. Millennium Management LLC now owns 383,966 shares of the company’s stock valued at $6,627,000 after buying an additional 263,442 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in shares of Envista by 39.3% during the first quarter. Goldman Sachs Group Inc. now owns 629,140 shares of the company’s stock valued at $10,859,000 after buying an additional 177,630 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Envista by 15.5% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 568,982 shares of the company’s stock valued at $9,821,000 after buying an additional 76,246 shares during the last quarter. Finally, Prudential Financial Inc. grew its stake in shares of Envista by 22.1% during the second quarter. Prudential Financial Inc. now owns 18,785 shares of the company’s stock valued at $367,000 after buying an additional 3,395 shares during the last quarter.

Envista Stock Performance

Envista stock opened at $23.08 on Monday. The company has a current ratio of 2.44, a quick ratio of 2.06 and a debt-to-equity ratio of 0.47. The firm has a 50-day moving average of $25.13 and a 200-day moving average of $24.58. The firm has a market cap of $3.76 billion, a P/E ratio of 56.29, a P/E/G ratio of 1.31 and a beta of 0.88. Envista Holdings Corporation has a 1-year low of $18.25 and a 1-year high of $30.42.

Envista (NYSE:NVST) last posted its earnings results on Wednesday, May 6th. The company reported $0.36 earnings per share for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. The company had revenue of $705.50 million during the quarter, compared to analyst estimates of $680.04 million. Envista had a net margin of 2.41% and a return on equity of 7.11%. Envista’s revenue for the quarter was up 14.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.24 earnings per share. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Sell-side analysts expect that Envista Holdings Corporation will post 1.42 EPS for the current year.

Wall Street Analysts Forecast Growth

NVST has been the topic of a number of recent research reports. Morgan Stanley raised their price objective on Envista from $19.00 to $21.00 and gave the company an “equal weight” rating in a research note on Friday, April 24th. Mizuho raised their price objective on Envista from $24.00 to $27.00 and gave the company a “neutral” rating in a research note on Tuesday, February 10th. Wall Street Zen cut Envista from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 9th. Zacks Research cut Envista from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Finally, JPMorgan Chase & Co. raised their price objective on Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Six investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $28.83.

Envista Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.